{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:28:20Z","timestamp":1778279300647,"version":"3.51.4"},"reference-count":15,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,9,12]]},"abstract":"<jats:p>A 38-year-old woman presented to casualty with bilateral red eyes associated with a recent upper respiratory tract infection. This was initially diagnosed as conjunctivitis, however systemic review revealed an erythematous facial and skin rash, mildly swollen lips and mild swallowing difficulties. The patient was referred for an urgent medical assessment, by which time she was found to have erythema affecting 54% of her body surface area and diagnosed with suspected toxic epidermal necrolysis (TEN). She rapidly deteriorated over 24\u2009hours with a spreading blistering skin rash and airway compromise requiring urgent intubation and admission to the intensive treatment unit (ITU). Subsequent skin biopsies confirmed the diagnosis of TEN, attributed to recent use of ibuprofen. Treatment included broad-spectrum antibiotics and high-dose corticosteroids. The patient had a prolonged hospital stay and developed severe scarring of the ocular surface. She was discharged home and remains under continuing outpatient follow-up with ophthalmology and dermatology teams.<\/jats:p>","DOI":"10.1136\/bcr-2018-225861","type":"journal-article","created":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T05:44:32Z","timestamp":1539409472000},"page":"bcr-2018-225861","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Toxic epidermal necrolysis: the red eye and red herrings in casualty"],"prefix":"10.1136","volume":"2018","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6435-0048","authenticated-orcid":false,"given":"Robert J","family":"Barry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulises","family":"Zanetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai","family":"Kolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupal","family":"Morjaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,10,12]]},"reference":[{"key":"2025042706325425000_2018.oct12_1.bcr-2018-225861.1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00061.x"},{"key":"2025042706325425000_2018.oct12_1.bcr-2018-225861.2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.72.10.733"},{"key":"2025042706325425000_2018.oct12_1.bcr-2018-225861.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2015.04.001"},{"key":"2025042706325425000_2018.oct12_1.bcr-2018-225861.4","first-page":"924","article-title":"The treatment of acute infectious conjunctivitis with fusidic acid: a randomised controlled trial","volume":"55","author":"Rietveld","year":"2005","journal-title":"Br J Gen Pract"},{"key":"2025042706325425000_2018.oct12_1.bcr-2018-225861.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66709-8"},{"key":"2025042706325425000_2018.oct12_1.bcr-2018-225861.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38891.551088.7C"},{"key":"2025042706325425000_2018.oct12_1.bcr-2018-225861.7","first-page":"1","article-title":"An updated review of the molecular mechanisms in drug hypersensitivity","volume":"2018","author":"Chen","year":"2018","journal-title":"J Immunol Res"},{"key":"2025042706325425000_2018.oct12_1.bcr-2018-225861.8","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/ICO.0000000000000646","article-title":"Incidence of Stevens-Johnson syndrome and chemical burns to the eye","volume":"34","author":"White","year":"2015","journal-title":"Cornea"},{"key":"2025042706325425000_2018.oct12_1.bcr-2018-225861.9","first-page":"e119","article-title":"UK guidelines for the management of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"69","author":"Creamer","year":"2016","journal-title":"J\u00a0of Plast Reconstr\u00a0Aesthetic Surg"},{"key":"2025042706325425000_2018.oct12_1.bcr-2018-225861.10","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1993.01680220104023"},{"key":"2025042706325425000_2018.oct12_1.bcr-2018-225861.11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jtos.2015.10.002","article-title":"Stevens-Johnson Syndrome\/toxic epidermal necrolysis--a comprehensive review and guide to therapy. i. systemic disease","volume":"14","author":"Kohanim","year":"2016","journal-title":"Ocul Surf"},{"key":"2025042706325425000_2018.oct12_1.bcr-2018-225861.12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jtos.2016.02.001","article-title":"Acute and chronic ophthalmic involvement in Stevens-Johnson syndrome\/toxic epidermal necrolysis - a comprehensive review and guide to therapy. ii. ophthalmic disease","volume":"14","author":"Kohanim","year":"2016","journal-title":"Ocul Surf"},{"key":"2025042706325425000_2018.oct12_1.bcr-2018-225861.13","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/ICU.0000000000000312","article-title":"Ocular manifestations of Stevens-Johnson syndrome and their management","volume":"27","author":"Saeed","year":"2016","journal-title":"Curr Opin Ophthalmol"},{"key":"2025042706325425000_2018.oct12_1.bcr-2018-225861.14","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.ophtha.2016.04.041","article-title":"New grading system and treatment guidelines for the acute ocular manifestations of Stevens-Johnson syndrome","volume":"123","author":"Gregory","year":"2016","journal-title":"Ophthalmology"},{"key":"2025042706325425000_2018.oct12_1.bcr-2018-225861.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512143332404"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-225861","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T13:33:06Z","timestamp":1745760786000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-225861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,12]]},"references-count":15,"alternative-id":["10.1136\/bcr-2018-225861"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-225861","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,12]]}}}